JBS

High-yield stocks are attractive for easy-to-understand reasons. When they outpace the S&P 500's average yield and inflation, they can provide substantial income.

The world's largest meatpacker, is preparing to close a beef-processing plant in Pennsylvania, the latest facility to close as a cattle shortage in the U.S. squeezes meatpacking companies.

GREELEY, Colo., June 12, 2026 (GLOBE NEWSWIRE) -- JBS USA today announced the planned closure of two facilities in Pennsylvania and Tennessee. The company emphasized its commitment to supporting those affected as it makes targeted changes to strengthen operations for the future.

JBS NYSE: JBS reported record first-quarter sales but lower profitability as executives said the global protein company faced difficult market conditions in U.S. beef, seasonal pressures, operational adjustments and shifting trade flows.

JBS N.V. (JBS) Q1 2026 Earnings Call Transcript

GREELEY, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- JBS USA Food Company Holdings announced today the total consideration payable in connection with its previously announced tenders offers (the “Tender Offers”) to purchase for cash a combined aggregate principal amount of up to $1,200,000,000 of the aggregate principal amount (the “Maximum Amount”) of its 6.750% Senior Notes due 2034 (the “2034 Notes”) and its 5.950% Senior Notes due 2035 (the “2035 Notes” and, together with the 2034 Notes, the “Notes”), subject to the terms and conditions of the Tender Offers.

Workers at JBS ratified a tentative two-year agreement with the world's largest meat company, ​covering nearly 3,800 workers at the JBS flagship beef ‌processing plant in Greeley, Colorado, according to statements from both the union and the company on Sunday.

The agreement covering 3,800 employees includes pay bumps through 2027.

I reiterate my buy rating on JBS as dual listing and potential Russell 1000 inclusion drive value unlock. JBS's diversified global protein business, robust revenue growth, and leading ROE support its investment appeal despite historical valuation discounts. Trading at 5.7x EBITDA versus peers' 8.65x, JBS offers up to 51% upside if multiples converge; even conservative peer comparison suggests 14% upside.

Strong performance across Pilgrim's Pride, JBS Australia and Seara showcases breadth of the JBS portfolio; earnings per share of US$ 1.89 reflect 15% growth Strong performance across Pilgrim's Pride, JBS Australia and Seara showcases breadth of the JBS portfolio; earnings per share of US$ 1.89 reflect 15% growth